Evaluating Improvement Strategies in Addiction Treatment

Status Completed

Clinical Trial Summary

Addiction treatment is often characterized by long delays between first contact and treatment as well as high no-show and drop out rates leading to unused capacity in apparently full agencies. Patients do not get needed care and agency financial stability is threatened. The Network for Improvement of Addiction Treatment (NIATx) began as a high-intensity improvement collaborative of 39 addiction treatment agencies distributed across 25 states. NIATx substantially improved time to treatment and continuation in treatment by making improvements to organizational processes (such as first contact, intake and assessment, engagement, level of care transitions, paperwork, social support, outreach, and scheduling) in preliminary studies. While the results are very encouraging, they have, by intent, been obtained from a select group of agencies using a high-cost combination of services. A more practical diffusion model is needed to spread process improvements across the spectrum of treatment agencies. This study is a cluster-randomized trial to test the effectiveness and cost of less expensive combinations of the services that make up the NIATx collaborative (interest circles, coach calls, coach visits and learning sessions).

Clinical Trial Description

This cluster-RCT randomly assign 201 treatment agencies in 5 states to four experimental arms. The agencies were randomized to an intervention for 18 months with a 9 month sustainability period. The study aimed to: 1) Determine whether a state-based strategy can (with NIATx support) can lead mainstream treatment agencies to implement and sustain process changes that improve the study's primary outcomes: time to treatment, annual clinic admissions, and continuation in treatment; and 2) Evaluate the effectiveness and cost of the services making up NIATx. This study aims to create a practical model for improving efficiency and effectiveness of addiction treatment. ;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00934141
Study type	Interventional
Source	University of Wisconsin, Madison
Contact
Status	Completed
Phase	Phase 3
Start date	October 2006
Completion date	January 2011

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT03576768` - QuitFast: Evaluating Transcranial Magnetic Stimulation as a Tool to Reduce Smoking Directly Following a Quit Attempt	N/A
Completed	`NCT04110626` - Realistic Evaluation of Expériences Animées, a School-based Intervention in Nouvelle Aquitaine
Completed	`NCT03007940` - Using NIATx Strategies to Implement Integrated Services in Routine Care	N/A
Not yet recruiting	`NCT04030858` - The INFINITE Study: A Prospective Investigation of a Nutrient-dense Diet in Early Addiction Recovery	N/A
Completed	`NCT03347643` - The Effectiveness of tDCS on Internet Game Addiction	Phase 2
Active, not recruiting	`NCT02836080` - Integrated Collaborative Care Teams for Youth With Mental Health and/or Addiction Challenges (YouthCan IMPACT)	N/A
Completed	`NCT03221985` - ESM Pilot: Mobile Phones and Psychology	N/A
Completed	`NCT02556060` - Lamotrigine for Ketamine Dependence Trial	Phase 2/Phase 3
Completed	`NCT02812810` - Evaluation of the Efficacy of Repetitive Transcranial Magnetic Stimulation (rTMS) Low-frequency on Craving in Smoking Dependence	N/A
Completed	`NCT01531153` - Cognitive Enhancement as a Target for Cocaine Pharmacotherapy	N/A
Recruiting	`NCT05976646` - Phase Ib/2a Drug-drug Interaction Study of a Combination of 45mg Dextromethorphan With 105 mg Bupropion	Phase 1/Phase 2
Completed	`NCT04409106` - The Turkish Version of the Parental Smartphone Use Management Scale (PSUMS)
Not yet recruiting	`NCT06459609` - Effect of Protein Supplementation on Craving in Subjects Hospitalised for Addiction Treatment	N/A
Recruiting	`NCT05595759` - Violence Against Women in Patients With Alcohol Substance Addiction Training	N/A
Completed	`NCT04099173` - A Brief Mindfulness-Based Intervention for Suicidal Ideation	N/A
Recruiting	`NCT04959643` - Systematic Screening for Viral Hepatitis B and C at the PASS Consultation of the Montpellier University Hospital
Completed	`NCT04133688` - Mobile App in Addiction	N/A
Recruiting	`NCT04063267` - Electronic Cigarettes as a Harm Reduction Strategy in Individuals With Substance Use Disorder	Phase 2
Completed	`NCT05114577` - Recovery Sleepers: A Pilot Study of a Sleep Health Intervention for College Students in Recovery	N/A
Terminated	`NCT02671240` - Prognosis of Behavioral Addiction in Parkinson's Disease

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Evaluating Improvement Strategies in Addiction Treatment — NIATx 200

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms